Trial Profile
Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients in Real Life Condition in Czech Republic (UFO).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Beclometasone/formoterol; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms UFO
- Sponsors AstraZeneca
- 22 Jul 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.